Apothecary Pharma LLC recalls

2 recalls.

• Apothecary NAD+ Injection 200 mg/mL recall (Apothecary Pharma LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility
• Tirzepatide Injection recall (Apothecary Pharma LLC)
  DrugClass IIReported October 14, 2026 · Lack of Assurance of Sterility